We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
CRISPR Therapeutics presented CTX310 — a one-time gene therapy that reduces triglycerides by 82% and LDL by 86%. Learn about the revolution in dyslipidemia treatment and market prospects.
